CSPHF
Price
$0.52
Change
+$0.24 (+85.71%)
Updated
Feb 27 closing price
Capitalization
504.63M
SIGY
Price
$4.15
Change
+$0.15 (+3.75%)
Updated
Mar 31 closing price
Capitalization
6.66M
Ad is loading...

CSPHF vs SIGY

Header iconCSPHF vs SIGY Comparison
Open Charts CSPHF vs SIGYBanner chart's image
CSTONE PHARMACEUTICALS
Price$0.52
Change+$0.24 (+85.71%)
Volume$5K
Capitalization504.63M
Sigyn Therapeutics
Price$4.15
Change+$0.15 (+3.75%)
Volume$200
Capitalization6.66M
CSPHF vs SIGY Comparison Chart
Loading...
View a ticker or compare two or three
VS
CSPHF vs. SIGY commentary
Apr 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPHF is a Hold and SIGY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 06, 2025
Stock price -- (CSPHF: $0.52 vs. SIGY: $4.15)
Brand notoriety: CSPHF and SIGY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSPHF: 162% vs. SIGY: 69%
Market capitalization -- CSPHF: $504.63M vs. SIGY: $6.66M
CSPHF [@Biotechnology] is valued at $504.63M. SIGY’s [@Biotechnology] market capitalization is $6.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSPHF’s FA Score shows that 0 FA rating(s) are green whileSIGY’s FA Score has 0 green FA rating(s).

  • CSPHF’s FA Score: 0 green, 5 red.
  • SIGY’s FA Score: 0 green, 5 red.
According to our system of comparison, both CSPHF and SIGY are a bad buy in the long-term.

Price Growth

CSPHF (@Biotechnology) experienced а 0.00% price change this week, while SIGY (@Biotechnology) price change was +3.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.00%. For the same industry, the average monthly price growth was -16.69%, and the average quarterly price growth was -18.23%.

Industries' Descriptions

@Biotechnology (-11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
CSPHF($505M) has a higher market cap than SIGY($6.66M). CSPHF YTD gains are higher at: 129.756 vs. SIGY (31.746).
CSPHFSIGYCSPHF / SIGY
Capitalization505M6.66M7,580%
EBITDAN/A-2.65M-
Gain YTD129.75631.746409%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A165K-
Total DebtN/A1.93M-
FUNDAMENTALS RATINGS
SIGY: Fundamental Ratings
SIGY
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVSCX12.77N/A
N/A
Janus Henderson Small-Mid Cap Value C
FIDJX12.42N/A
N/A
Fidelity SAI Sustainable Sector Fund
REREX52.65N/A
N/A
American Funds Europacific Growth R4
ABSAX19.06N/A
N/A
American Beacon Small Cp Val A
LYRCX24.12N/A
N/A
Lyrical US Value Equity C

CSPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSPHF has been loosely correlated with DVHGF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CSPHF jumps, then DVHGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPHF
1D Price
Change %
CSPHF100%
N/A
DVHGF - CSPHF
38%
Loosely correlated
N/A
WINT - CSPHF
24%
Poorly correlated
+5.69%
BCAB - CSPHF
9%
Poorly correlated
-6.57%
SIGY - CSPHF
8%
Poorly correlated
N/A
NBTX - CSPHF
7%
Poorly correlated
-3.40%
More

SIGY and

Correlation & Price change

A.I.dvisor tells us that SIGY and OTLK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGY and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGY
1D Price
Change %
SIGY100%
N/A
OTLK - SIGY
23%
Poorly correlated
-0.83%
ACHV - SIGY
21%
Poorly correlated
-9.92%
KALA - SIGY
21%
Poorly correlated
-8.32%
CSPHF - SIGY
8%
Poorly correlated
N/A
CPMV - SIGY
6%
Poorly correlated
-2.99%
More